Arihant Capital Markets Ltd ("Manager to the Offer") has informed BSE regarding Open Offer for acquisition of 35,73,515 Equity Shares from shareholders of Krebs Biochemicals & Industries Ltd ("Target Company") by Ipca Laboratories Limited, Mumbai (Acquirer)<BR><BR>Offer Details:<BR><BR>Size: 35,73,515 fully paid up equity shares of face value of Rs. 10/- each constituting 26% of the fully diluted Equity and voting Share Capital of the Target Company, post preferential allotment and conversion of warrants issued on preferential basis<BR><BR>Price/consideration : Cash offer of Rs. 54/- (Rupees Fifty Four only) per Equity Share.
|